Gene · 824
Papers2,355
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
1 to 20 of 2,355
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| A prostate cancer-specific super-enhancer at 1q42.3 regulates the CAPN2 and KRT19. | J Biol Chem | 2026 | 42772564 | PubTator, text mining | PubMed |
| Calcium-dependent proteolysis of the chimeric androglobin reveals altered localization of its isolated globin domain. | J Biol Chem | 2026 | 42759662 | PubTator, text mining | PubMed |
| Calpain-2 as a therapeutic target for sodium danshensu in mitigating myocardial ischaemia-reperfusion injury. | Br J Pharmacol | 2026 | 42615330 | PubTator, text mining | PubMed |
| Calpain-2 inhibition prevents pressure overload-induced lysosomal cathepsin release and cardiac hypertrophy. | Life Sci | 2026 | 42567498 | PubTator, text mining | PubMed |
| Genome-wide association susceptibility loci for cluster headache support a role for inflammation in the pathophysiology. | J Headache Pain | 2026 | 42557554 | PubTator, text mining | PubMed |
| Gut microbiome derived folate metabolite suppresses colorectal cancer progression. | bioRxiv | 2026 | 42523540 | PubTator, text mining | PubMed |
| DINCH exposure contributes to osteoarthritis pathogenesis via TSPO-mediated chondrotoxicity: Evidence from in silico prediction to experimental validation. | Chem Biol Interact | 2026 | 42501774 | PubTator, text mining | PubMed |
| Therapeutic potential of pachymic acid in glioma: a comprehensive approach combining experimental validation, network pharmacology, and machine learning. | Brain Res | 2026 | 42468874 | PubTator, text mining | PubMed |
| Preclinical evaluation of cysteine protease-inhibitor aloxistatin (E64d) for heart failure therapy. | J Mol Med (Berl) | 2026 | 42343037 | PubTator, text mining | PubMed |
| Integrated network toxicology and experimental validation to investigate potential mechanisms associated with aspartame-induced malignant phenotypic changes in colorectal cancer. | Naunyn Schmiedebergs Arch Pharmacol | 2026 | 42319418 | PubTator, text mining | PubMed |
| Calpain-2 inhibition alleviates hypercalcemia-driven multiple myeloma progression. | Biochem Pharmacol | 2026 | 42315074 | PubTator, text mining | PubMed |
| Targeting neuropilin-1 attenuates 4-hydroxytamoxifen-induced stemness and sensitizes ERα-re-expressing TNBC to tamoxifen. | Biochem Pharmacol | 2026 | 42285368 | PubTator, text mining | PubMed |
| Convergent immune dysregulation in sepsis and colorectal cancer highlights plasma cells and identifies shared candidate genes. | Discov Oncol | 2026 | 42213300 | PubTator, text mining | PubMed |
| Retraction Note to: Degradation of βII-Spectrin Protein by Calpain-2 and Caspase-3 Under Neurotoxic and Traumatic Brain Injury Conditions. | Mol Neurobiol | 2026 | 42168513 | PubTator, text mining | PubMed |
| Correction: Accumulation of human full-length tau induces degradation of nicotinic acetylcholine receptor α4 via activating calpain-2. | Sci Rep | 2026 | 42156794 | PubTator, text mining | PubMed |
| Active Colitis Attenuates Ventricular Excitation-Contraction Coupling by T-Tubular Remodeling. | Biomolecules | 2026 | 42072624 | PubTator, text mining | PubMed |
| The Role of Piezo 1 in the Study of Intervertebral Disc Degeneration: Phenotype, Mechanism and Treatment. | Orthop Surg | 2026 | 41942106 | PubTator, text mining | PubMed |
| A small-molecule stabilizer of the calpastatin-calpain-2 complex restores mitochondrial function and mitigates neurodegeneration. | Sci Adv | 2026 | 41894510 | PubTator, text mining | PubMed |
| Heterogeneous nuclear ribonucleoprotein K in cancer biology and its therapeutic applications (Review). | Mol Med Rep | 2026 | 41891975 | PubTator, text mining | PubMed |
| Single-cell multiomics uncovers an endothelial mechanosensitive PIEZO1-IL-33 axis driving pulmonary fibrosis. | Nat Commun | 2026 | 41862476 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/824/papers